RCKTW
Rocket Pharmaceuticals, Inc. Warrant$0.01-0.00 (-1.00%)Prev Close$0.01·MCap—·P/E—·Vol9.8K·Yield—
▲
Buys (12M)
2
$68.5K
▼
Sells (12M)
28
$466.8K
◆
Net Activity
Net Seller
$398.3K
●
Active Insiders
7
last 12 mo
Over the past 12 months, insider activity at Rocket Pharmaceuticals, Inc. Warrant (RCKTW) has been dominated by selling, with 2 insider purchases totaling $68.5K and 28 insider sales totaling $466.8K. The most recent insider transaction was by Militello John (See Remarks), who sold $3.9K worth of shares on Feb 18, 2026. Rocket Pharmaceuticals, Inc. Warrant operates in the Technology sector, within the General industry.
RCKTW Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Militello John | See Remarks | Sell | 1,157 | $3.34 | $3.9K | 0 |
| Feb 18, 2026 | Shah Gaurav | CEO | Sell | 5,990 | $3.34 | $20.0K | 0 |
| Feb 18, 2026 | Wilson Martin | General Counsel | Sell | 1,376 | $3.34 | $4.6K | 0 |
| Feb 13, 2026 | Militello John | See Remarks | Sell | 3,726 | $3.31 | $12.3K | 0 |
| Feb 13, 2026 | Shah Gaurav | CEO | Sell | 12,279 | $3.31 | $40.7K | 0 |
| Feb 13, 2026 | Wilson Martin | General Counsel | Sell | 12,253 | $3.31 | $40.6K | 0 |
| Jan 6, 2026 | Bjork Elisabeth | Buy | 10,000 | $3.44 | $34.4K | 50,000+25% | |
| Nov 20, 2025 | Militello John | See Remarks | Sell | 1,086 | $2.98 | $3.2K | 65,920 |
| Nov 20, 2025 | Schwartz Jonathan David | See Remarks | Sell | 2,545 | $2.98 | $7.6K | 299,064 |
| Nov 20, 2025 | Shah Gaurav | CEO | Sell | 6,276 | $2.98 | $18.7K | 778,296 |
| Nov 20, 2025 | Wilson Martin | General Counsel | Sell | 1,646 | $2.98 | $4.9K | 383,816 |
| Oct 16, 2025 | Militello John | See Remarks | Sell | 28,918 | $3.96 | $114.6K | 76,083-28% |
| Aug 27, 2025 | Bjork Elisabeth | Buy | 10,000 | $3.41 | $34.1K | 40,000+33% | |
| Aug 20, 2025 | Militello John | See Remarks | Sell | 1,060 | $3.04 | $3.2K | 56,285 |
| Aug 20, 2025 | Schwartz Jonathan David | See Remarks | Sell | 2,485 | $3.04 | $7.6K | 222,414 |
| Aug 20, 2025 | Wilson Martin | General Counsel | Sell | 1,592 | $3.04 | $4.8K | 136,050 |
| Aug 18, 2025 | Militello John | See Remarks | Sell | 7,043 | $3.02 | $21.3K | 56,984 |
| Aug 18, 2025 | Schwartz Jonathan David | See Remarks | Sell | 11,161 | $3.02 | $33.7K | 224,094 |
| Aug 18, 2025 | Wilson Martin | General Counsel | Sell | 12,109 | $3.02 | $36.6K | 137,054 |
| Jul 8, 2025 | Ondrey Aaron | Chief Financial Officer | Sell | 1,477 | $2.88 | $4.3K | 128,173 |
| May 22, 2025 | Militello John | See Remarks | Sell | 357 | $6.45 | $2.3K | 64,027 |
| May 22, 2025 | Patel Kinnari | See Remarks | Sell | 767 | $6.45 | $4.9K | 441,927 |
| May 22, 2025 | Schwartz Jonathan David | See Remarks | Sell | 801 | $6.45 | $5.2K | 235,255 |
| May 22, 2025 | Shah Gaurav | CEO | Sell | 2,253 | $6.45 | $14.5K | 786,806 |
| May 22, 2025 | Wilson Martin | General Counsel | Sell | 587 | $6.45 | $3.8K | 149,163 |
| May 20, 2025 | Militello John | See Remarks | Sell | 655 | $6.53 | $4.3K | 64,384 |
| May 20, 2025 | Patel Kinnari | See Remarks | Sell | 1,409 | $6.53 | $9.2K | 442,694 |
| May 20, 2025 | Schwartz Jonathan David | See Remarks | Sell | 1,582 | $6.53 | $10.3K | 236,056 |
| May 20, 2025 | Shah Gaurav | CEO | Sell | 3,621 | $6.53 | $23.6K | 789,059 |
| May 20, 2025 | Wilson Martin | General Counsel | Sell | 946 | $6.53 | $6.2K | 149,750 |
| Apr 24, 2025 | Militello John | See Remarks | Sell | 718 | $7.16 | $5.1K | 65,039 |
| Apr 14, 2025 | Shah Gaurav | CEO | Buy | 20,000 | $5.08 | $101.6K | 792,680 |
| Apr 10, 2025 | Patel Kinnari | See Remarks | Buy | 21,099 | $4.70 | $99.2K | 26,774+372% |
| Apr 8, 2025 | Ondrey Aaron | Chief Financial Officer | Sell | 7,489 | $5.29 | $39.6K | 129,650 |
| Feb 27, 2025 | Schwartz Jonathan David | See Remarks | Sell | 15,093 | $14.84 | $224.0K | 237,638 |
| Feb 25, 2025 | Militello John | See Remarks | Sell | 2,737 | $10.58 | $29.0K | 65,757 |
| Feb 25, 2025 | Patel Kinnari | See Remarks | Sell | 6,078 | $10.58 | $64.3K | 444,103 |
| Feb 25, 2025 | Shah Gaurav | CEO | Sell | 16,303 | $10.58 | $172.5K | 772,680 |
| Feb 25, 2025 | Wilson Martin | General Counsel | Sell | 3,222 | $10.58 | $34.1K | 150,696 |
| Jan 27, 2025 | Militello John | See Remarks | Sell | 896 | $10.38 | $9.3K | 48,414 |
| Nov 25, 2024 | Militello John | See Remarks | Sell | 1,224 | $13.05 | $16.0K | 49,310 |
| Nov 25, 2024 | Patel Kinnari | See Remarks | Sell | 4,588 | $13.05 | $59.9K | 392,395 |
| Nov 25, 2024 | Shah Gaurav | CEO | Sell | 11,091 | $13.05 | $144.8K | 707,328 |
| Nov 25, 2024 | Wilson Martin | General Counsel | Sell | 1,175 | $13.05 | $15.3K | 63,560 |
| Nov 4, 2024 | Militello John | See Remarks | Sell | 917 | $16.62 | $15.2K | 50,534 |
| Nov 4, 2024 | White Mark Andrew | See Remarks | Sell | 3,080 | $16.63 | $51.2K | 69,140 |
| Aug 20, 2024 | Shah Gaurav | CEO | Sell | 9,650 | $18.50 | $178.6K | 718,419 |
| Aug 20, 2024 | Patel Kinnari | See Remarks | Sell | 3,989 | $18.50 | $73.8K | 396,983 |
| Aug 20, 2024 | Militello John | See Remarks | Sell | 1,064 | $18.50 | $19.7K | 51,451 |
| Aug 20, 2024 | Wilson Martin | General Counsel | Sell | 1,027 | $18.50 | $19.0K | 64,735 |
Showing 1–50 of 83
1 / 2
RCKTW Insider Buying Activity
The following table shows recent insider purchases of Rocket Pharmaceuticals, Inc. Warrant (RCKTW) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | Bjork Elisabeth | Buy | 10,000 | $3.44 | $34.4K | 50,000+25% | |
| Aug 27, 2025 | Bjork Elisabeth | Buy | 10,000 | $3.41 | $34.1K | 40,000+33% | |
| Apr 14, 2025 | Shah Gaurav | CEO | Buy | 20,000 | $5.08 | $101.6K | 792,680 |
| Apr 10, 2025 | Patel Kinnari | See Remarks | Buy | 21,099 | $4.70 | $99.2K | 26,774+372% |
RCKTW Insider Selling Activity
The following table shows recent insider sales of Rocket Pharmaceuticals, Inc. Warrant (RCKTW) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Militello John | See Remarks | Sell | 1,157 | $3.34 | $3.9K | 0 |
| Feb 18, 2026 | Shah Gaurav | CEO | Sell | 5,990 | $3.34 | $20.0K | 0 |
| Feb 18, 2026 | Wilson Martin | General Counsel | Sell | 1,376 | $3.34 | $4.6K | 0 |
| Feb 13, 2026 | Militello John | See Remarks | Sell | 3,726 | $3.31 | $12.3K | 0 |
| Feb 13, 2026 | Shah Gaurav | CEO | Sell | 12,279 | $3.31 | $40.7K | 0 |
| Feb 13, 2026 | Wilson Martin | General Counsel | Sell | 12,253 | $3.31 | $40.6K | 0 |
| Nov 20, 2025 | Militello John | See Remarks | Sell | 1,086 | $2.98 | $3.2K | 65,920 |
| Nov 20, 2025 | Schwartz Jonathan David | See Remarks | Sell | 2,545 | $2.98 | $7.6K | 299,064 |
| Nov 20, 2025 | Shah Gaurav | CEO | Sell | 6,276 | $2.98 | $18.7K | 778,296 |
| Nov 20, 2025 | Wilson Martin | General Counsel | Sell | 1,646 | $2.98 | $4.9K | 383,816 |
| Oct 16, 2025 | Militello John | See Remarks | Sell | 28,918 | $3.96 | $114.6K | 76,083-28% |
| Aug 20, 2025 | Militello John | See Remarks | Sell | 1,060 | $3.04 | $3.2K | 56,285 |
| Aug 20, 2025 | Schwartz Jonathan David | See Remarks | Sell | 2,485 | $3.04 | $7.6K | 222,414 |
| Aug 20, 2025 | Wilson Martin | General Counsel | Sell | 1,592 | $3.04 | $4.8K | 136,050 |
| Aug 18, 2025 | Militello John | See Remarks | Sell | 7,043 | $3.02 | $21.3K | 56,984 |
| Aug 18, 2025 | Schwartz Jonathan David | See Remarks | Sell | 11,161 | $3.02 | $33.7K | 224,094 |
| Aug 18, 2025 | Wilson Martin | General Counsel | Sell | 12,109 | $3.02 | $36.6K | 137,054 |
| Jul 8, 2025 | Ondrey Aaron | Chief Financial Officer | Sell | 1,477 | $2.88 | $4.3K | 128,173 |
| May 22, 2025 | Militello John | See Remarks | Sell | 357 | $6.45 | $2.3K | 64,027 |
| May 22, 2025 | Patel Kinnari | See Remarks | Sell | 767 | $6.45 | $4.9K | 441,927 |
| May 22, 2025 | Schwartz Jonathan David | See Remarks | Sell | 801 | $6.45 | $5.2K | 235,255 |
| May 22, 2025 | Shah Gaurav | CEO | Sell | 2,253 | $6.45 | $14.5K | 786,806 |
| May 22, 2025 | Wilson Martin | General Counsel | Sell | 587 | $6.45 | $3.8K | 149,163 |
| May 20, 2025 | Militello John | See Remarks | Sell | 655 | $6.53 | $4.3K | 64,384 |
| May 20, 2025 | Patel Kinnari | See Remarks | Sell | 1,409 | $6.53 | $9.2K | 442,694 |
| May 20, 2025 | Schwartz Jonathan David | See Remarks | Sell | 1,582 | $6.53 | $10.3K | 236,056 |
| May 20, 2025 | Shah Gaurav | CEO | Sell | 3,621 | $6.53 | $23.6K | 789,059 |
| May 20, 2025 | Wilson Martin | General Counsel | Sell | 946 | $6.53 | $6.2K | 149,750 |
| Apr 24, 2025 | Militello John | See Remarks | Sell | 718 | $7.16 | $5.1K | 65,039 |
| Apr 8, 2025 | Ondrey Aaron | Chief Financial Officer | Sell | 7,489 | $5.29 | $39.6K | 129,650 |
| Feb 27, 2025 | Schwartz Jonathan David | See Remarks | Sell | 15,093 | $14.84 | $224.0K | 237,638 |
| Feb 25, 2025 | Militello John | See Remarks | Sell | 2,737 | $10.58 | $29.0K | 65,757 |
| Feb 25, 2025 | Patel Kinnari | See Remarks | Sell | 6,078 | $10.58 | $64.3K | 444,103 |
| Feb 25, 2025 | Shah Gaurav | CEO | Sell | 16,303 | $10.58 | $172.5K | 772,680 |
| Feb 25, 2025 | Wilson Martin | General Counsel | Sell | 3,222 | $10.58 | $34.1K | 150,696 |
| Jan 27, 2025 | Militello John | See Remarks | Sell | 896 | $10.38 | $9.3K | 48,414 |
| Nov 25, 2024 | Militello John | See Remarks | Sell | 1,224 | $13.05 | $16.0K | 49,310 |
| Nov 25, 2024 | Patel Kinnari | See Remarks | Sell | 4,588 | $13.05 | $59.9K | 392,395 |
| Nov 25, 2024 | Shah Gaurav | CEO | Sell | 11,091 | $13.05 | $144.8K | 707,328 |
| Nov 25, 2024 | Wilson Martin | General Counsel | Sell | 1,175 | $13.05 | $15.3K | 63,560 |
| Nov 4, 2024 | Militello John | See Remarks | Sell | 917 | $16.62 | $15.2K | 50,534 |
| Nov 4, 2024 | White Mark Andrew | See Remarks | Sell | 3,080 | $16.63 | $51.2K | 69,140 |
| Aug 20, 2024 | Shah Gaurav | CEO | Sell | 9,650 | $18.50 | $178.6K | 718,419 |
| Aug 20, 2024 | Patel Kinnari | See Remarks | Sell | 3,989 | $18.50 | $73.8K | 396,983 |
| Aug 20, 2024 | Militello John | See Remarks | Sell | 1,064 | $18.50 | $19.7K | 51,451 |
| Aug 20, 2024 | Wilson Martin | General Counsel | Sell | 1,027 | $18.50 | $19.0K | 64,735 |
RCKTW Insiders
Similar Stocks to RCKTW
SATA
Strive, Inc. Variable Rate Series A Perpetual Preferred Stock
$99.99+0.00%
$65.96B
BTSGU
BrightSpring Health Services, Inc. Tangible Equity Unit
$158.42-1.55%
$24.31B
VLYPN
Valley National Bancorp 8.250% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series C
$26.15-0.38%
$14.53B
AGNCN
AGNC Investment Corp. Depositary Shares Each Representing a 1/1,000th Interest in a Share of 7 percent Series C Fixed-To-Floating Rate Cumulative Redeemable Preferred Stock
$25.71-0.27%
$8.80B
SLMBP
SLM Corporation Floating-Rate Non-Cumulative Series B
$74.40+0.54%
$6.75B
PFH
Prudential Financial, Inc. 4.125% Junior Subordinated Notes due 2060
$16.91-0.59%
$6.06B
VLYPP
Valley National Bancorp 6.25% Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock, Series A
$25.22+0.08%
$5.49B
BANFP
BancFirst Corporation - BFC Capital Trust II Cumulative Trust Pfd Secs
$26.22-0.98%
$4.18B